SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2v2f'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C4D_D_DVAD8_0 (GRAMICIDIN A)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	3 / 3	TRP F 368 VAL F 362 TRP F 596	None	1.35A	1c4dC-2v2fF: undetectable 1c4dD-2v2fF: undetectable	1c4dC-2v2fF: 3.92 1c4dD-2v2fF: 3.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HK3_A_T44A3003_1 (SERUM ALBUMIN)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	3 / 4	LYS F 446 ALA F 445 MET F 459	None	0.94A	1hk3A-2v2fF: undetectable	1hk3A-2v2fF: 20.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_A_CFXA1300_1 (BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	LYS F 373 SER F 428 ASN F 430 THR F 543 LYS F 557 GLY F 559	None MES F1653 (-3.1A) None MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.6A)	0.74A	1i2wA-2v2fF: 17.1	1i2wA-2v2fF: 21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_A_CFXA1300_1 (BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	SER F 370 SER F 428 ASN F 430 THR F 543 LYS F 557 GLY F 559	MES F1653 (-2.7A) MES F1653 (-3.1A) None MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.6A)	0.79A	1i2wA-2v2fF: 17.1	1i2wA-2v2fF: 21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MMW_A_H4BA1760_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	4 / 7	MET F 583 ARG F 366 VAL F 329 GLU F 582	None None None MES F1653 (-3.5A)	1.39A	1mmwA-2v2fF: undetectable 1mmwB-2v2fF: undetectable	1mmwA-2v2fF: 23.49 1mmwB-2v2fF: 23.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1N2X_B_SAMB402_1 (S-ADENOSYL-METHYLTRA NSFERASE MRAW)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	4 / 5	ASP F 335 VAL F 336 SER F 592 ASP F 303	None	1.35A	1n2xB-2v2fF: undetectable	1n2xB-2v2fF: 21.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YMX_A_CFXA1001_1 (BETA-LACTAMASE CTX-M-9)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	SER F 370 SER F 428 ASN F 430 THR F 543 LYS F 557 GLY F 559	MES F1653 (-2.7A) MES F1653 (-3.1A) None MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.6A)	0.78A	1ymxA-2v2fF: 17.7	1ymxA-2v2fF: 24.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2D55_C_DVAC8_0 (ACTINOMYCIN D)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	3 / 3	PRO F 380 THR F 376 PRO F 374	None	0.85A	2d55C-2v2fF: undetectable	2d55C-2v2fF: 3.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YOE_C_FL7C1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	4 / 8	GLY F 559 ILE F 454 THR F 376 TYR F 456	MES F1653 (-3.6A) None None None	0.90A	2yoeB-2v2fF: undetectable 2yoeC-2v2fF: undetectable	2yoeB-2v2fF: 19.80 2yoeC-2v2fF: 19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YZQ_A_SAMA6075_0 (PUTATIVE UNCHARACTERIZED PROTEIN PH1780)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	5 / 12	THR F 300 VAL F 302 ILE F 342 GLU F 481 GLN F 344	None	1.20A	2yzqA-2v2fF: undetectable	2yzqA-2v2fF: 21.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_A_CE3A301_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	LYS F 373 SER F 428 ASN F 430 THR F 543 LYS F 557 GLY F 559	None MES F1653 (-3.1A) None MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.6A)	0.68A	3hlwA-2v2fF: 17.6	3hlwA-2v2fF: 24.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_B_CE3B302_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	SER F 428 ASN F 430 THR F 543 LYS F 557 THR F 558 GLY F 559	MES F1653 (-3.1A) None MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A)	0.48A	3hlwB-2v2fF: 17.8	3hlwB-2v2fF: 24.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KP6_B_SALB3001_1 (TRANSCRIPTIONAL REGULATOR TCAR)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	4 / 8	GLU F 627 HIS F 309 MET F 621 ILE F 622	None	1.26A	3kp6A-2v2fF: undetectable 3kp6B-2v2fF: undetectable	3kp6A-2v2fF: 18.83 3kp6B-2v2fF: 18.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3L4D_A_TPFA490_1 (STEROL 14-ALPHA DEMETHYLASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	4 / 8	TYR F 618 ALA F 488 ALA F 491 MET F 535	None	0.96A	3l4dA-2v2fF: undetectable	3l4dA-2v2fF: 19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N5V_A_H4BA760_1 (NITRIC OXIDE SYNTHASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	4 / 7	MET F 583 ARG F 366 VAL F 329 GLU F 582	None None None MES F1653 (-3.5A)	1.38A	3n5vA-2v2fF: undetectable 3n5vB-2v2fF: undetectable	3n5vA-2v2fF: 23.81 3n5vB-2v2fF: 23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N5Y_A_H4BA760_1 (NITRIC OXIDE SYNTHASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	4 / 7	MET F 583 ARG F 366 VAL F 329 GLU F 582	None None None MES F1653 (-3.5A)	1.34A	3n5yA-2v2fF: undetectable 3n5yB-2v2fF: undetectable	3n5yA-2v2fF: 23.81 3n5yB-2v2fF: 23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N5Z_A_H4BA760_1 (NITRIC OXIDE SYNTHASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	4 / 7	MET F 583 ARG F 366 VAL F 329 GLU F 582	None None None MES F1653 (-3.5A)	1.36A	3n5zA-2v2fF: undetectable 3n5zB-2v2fF: undetectable	3n5zA-2v2fF: 23.81 3n5zB-2v2fF: 23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NY4_A_SMXA308_1 (BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	SER F 428 THR F 543 LYS F 557 THR F 558 GLY F 559 THR F 560	MES F1653 (-3.1A) MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A) MES F1653 (-3.6A)	0.70A	3ny4A-2v2fF: 16.4	3ny4A-2v2fF: 19.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q07_A_WPPA300_1 (BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	5 / 12	LYS F 373 SER F 428 ASN F 430 LYS F 557 GLY F 559	None MES F1653 (-3.1A) None MES F1653 ( 4.0A) MES F1653 (-3.6A)	0.61A	3q07A-2v2fF: 17.6	3q07A-2v2fF: 24.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q9A_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	4 / 7	MET F 583 ARG F 366 VAL F 329 GLU F 582	None None None MES F1653 (-3.5A)	1.39A	3q9aA-2v2fF: undetectable 3q9aB-2v2fF: undetectable	3q9aA-2v2fF: 23.81 3q9aB-2v2fF: 23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	7 / 12	LYS F 373 SER F 428 ASN F 430 THR F 543 LYS F 557 THR F 558 GLY F 559	None MES F1653 (-3.1A) None MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A)	0.85A	4euzA-2v2fF: 17.7	4euzA-2v2fF: 24.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	7 / 12	LYS F 373 SER F 428 THR F 543 LYS F 557 THR F 558 GLY F 559 THR F 560	None MES F1653 (-3.1A) MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A) MES F1653 (-3.6A)	0.95A	4euzA-2v2fF: 17.7	4euzA-2v2fF: 24.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	5 / 10	SER F 428 ASN F 430 LYS F 557 THR F 558 GLY F 559	MES F1653 (-3.1A) None MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A)	0.70A	4fh2A-2v2fF: 16.6	4fh2A-2v2fF: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MA7_A_P2ZA301_1 (MAJOR PRION PROTEIN)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	4 / 8	VAL F 538 LEU F 539 ILE F 622 VAL F 595	None	0.91A	4ma7A-2v2fF: undetectable	4ma7A-2v2fF: 13.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MM4_B_8PRB603_2 (TRANSPORTER)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	3 / 3	SER F 331 MET F 593 ASP F 581	None	0.92A	4mm4B-2v2fF: undetectable	4mm4B-2v2fF: 20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NQA_A_9CRA501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	5 / 11	ILE F 375 ALA F 379 LEU F 449 ALA F 445 VAL F 585	None	1.17A	4nqaA-2v2fF: undetectable	4nqaA-2v2fF: 21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM5_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	SER F 428 ASN F 430 THR F 543 LYS F 557 THR F 558 GLY F 559	MES F1653 (-3.1A) None MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A)	0.65A	4pm5A-2v2fF: 17.9	4pm5A-2v2fF: 24.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM7_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	5 / 12	LYS F 373 ASN F 430 THR F 543 LYS F 557 GLY F 559	None None MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.6A)	0.68A	4pm7A-2v2fF: 17.9	4pm7A-2v2fF: 24.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM7_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	5 / 12	SER F 428 ASN F 430 THR F 543 LYS F 557 GLY F 559	MES F1653 (-3.1A) None MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.6A)	0.68A	4pm7A-2v2fF: 17.9	4pm7A-2v2fF: 24.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM9_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	SER F 428 ASN F 430 THR F 543 LYS F 557 THR F 558 GLY F 559	MES F1653 (-3.1A) None MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A)	0.67A	4pm9A-2v2fF: 17.7	4pm9A-2v2fF: 24.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X1K_D_LOCD502_1 (TUBULIN ALPHA CHAIN TUBULIN BETA CHAIN)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	4 / 4	ASN F 274 SER F 331 ALA F 361 VAL F 362	None	1.41A	4x1kC-2v2fF: undetectable	4x1kC-2v2fF: 23.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VUJ_A_H4BA802_1 (NITRIC OXIDE SYNTHASE, BRAIN)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	4 / 7	MET F 583 ARG F 366 VAL F 329 GLU F 582	None None None MES F1653 (-3.5A)	1.34A	5vujA-2v2fF: undetectable 5vujB-2v2fF: undetectable	5vujA-2v2fF: 23.81 5vujB-2v2fF: 23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZMQ_K_PACK1_0 (SERINE PROTEASE NS3 PEPTIDE PAC-DLY-DLY-DAR)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	3 / 3	ALA F 343 VAL F 279 TYR F 501	None	0.71A	5zmqH-2v2fF: undetectable	5zmqH-2v2fF: 19.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	SER F 428 THR F 543 LYS F 557 THR F 558 GLY F 559 THR F 560	MES F1653 (-3.1A) MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A) MES F1653 (-3.6A)	0.73A	6b5yB-2v2fF: 7.2	6b5yB-2v2fF: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	SER F 428 THR F 543 LYS F 557 THR F 558 GLY F 559 THR F 560	MES F1653 (-3.1A) MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A) MES F1653 (-3.6A)	0.81A	6b5yD-2v2fF: 17.4	6b5yD-2v2fF: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	SER F 428 THR F 543 LYS F 557 THR F 558 GLY F 559 THR F 560	MES F1653 (-3.1A) MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A) MES F1653 (-3.6A)	0.59A	6b68B-2v2fF: 17.4	6b68B-2v2fF: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	5 / 12	SER F 428 THR F 543 LYS F 557 GLY F 559 THR F 560	MES F1653 (-3.1A) MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.6A) MES F1653 (-3.6A)	0.64A	6b68D-2v2fF: 17.5	6b68D-2v2fF: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	SER F 428 THR F 543 LYS F 557 THR F 558 GLY F 559 THR F 560	MES F1653 (-3.1A) MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A) MES F1653 (-3.6A)	0.56A	6b69A-2v2fF: 17.1 6b69B-2v2fF: 17.2	6b69A-2v2fF: 12.50 6b69B-2v2fF: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	SER F 370 SER F 428 THR F 543 LYS F 557 THR F 558 GLY F 559	MES F1653 (-2.7A) MES F1653 (-3.1A) MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A)	0.74A	6b69D-2v2fF: 7.3	6b69D-2v2fF: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	SER F 428 THR F 543 LYS F 557 THR F 558 GLY F 559 THR F 560	MES F1653 (-3.1A) MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A) MES F1653 (-3.6A)	0.57A	6b69D-2v2fF: 7.3	6b69D-2v2fF: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	SER F 428 THR F 543 LYS F 557 THR F 558 GLY F 559 THR F 560	MES F1653 (-3.1A) MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A) MES F1653 (-3.6A)	0.62A	6b6aB-2v2fF: 17.6	6b6aB-2v2fF: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	SER F 370 SER F 428 THR F 543 LYS F 557 THR F 558 GLY F 559	MES F1653 (-2.7A) MES F1653 (-3.1A) MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A)	0.84A	6b6dA-2v2fF: 17.3	6b6dA-2v2fF: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	SER F 428 THR F 543 LYS F 557 THR F 558 GLY F 559 THR F 560	MES F1653 (-3.1A) MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A) MES F1653 (-3.6A)	0.78A	6b6dA-2v2fF: 17.3	6b6dA-2v2fF: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	SER F 370 SER F 428 THR F 543 LYS F 557 THR F 558 GLY F 559	MES F1653 (-2.7A) MES F1653 (-3.1A) MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A)	0.81A	6b6eA-2v2fF: 17.5	6b6eA-2v2fF: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	6 / 12	SER F 428 THR F 543 LYS F 557 THR F 558 GLY F 559 THR F 560	MES F1653 (-3.1A) MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.8A) MES F1653 (-3.6A) MES F1653 (-3.6A)	0.65A	6b6eA-2v2fF: 17.5	6b6eA-2v2fF: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6C79_A_CE3A301_1 (BETA-LACTAMASE TOHO-1)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	5 / 12	SER F 428 ASN F 430 THR F 543 LYS F 557 GLY F 559	MES F1653 (-3.1A) None MES F1653 (-3.7A) MES F1653 ( 4.0A) MES F1653 (-3.6A)	0.47A	6c79A-2v2fF: 17.6	6c79A-2v2fF: 13.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_A_Y00A406_0 (BETA-1 ADRENERGIC RECEPTOR)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	5 / 12	VAL F 298 SER F 480 SER F 479 ASN F 359 VAL F 279	None	1.40A	6h7lA-2v2fF: undetectable	6h7lA-2v2fF: 12.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H7L_B_Y00B405_0 (BETA-1 ADRENERGIC RECEPTOR)	2v2f	PENICILLIN BINDING PROTEIN 1A (Streptococcus pneumoniae)	5 / 12	VAL F 298 SER F 480 SER F 479 ASN F 359 VAL F 279	None	1.42A	6h7lB-2v2fF: undetectable	6h7lB-2v2fF: 12.90

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1C4D_D_DVAD8_0","GRAMICIDIN A","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",3,"TRP F 368;VAL F 362;TRP F 596","None","1.35A","1c4dC-2v2fF:undetectable;1c4dD-2v2fF:undetectable","1c4dC-2v2fF:3.92;1c4dD-2v2fF:3.92"],["1HK3_A_T44A3003_1","SERUM ALBUMIN","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",3,"LYS F 446;ALA F 445;MET F 459","None","0.94A","1hk3A-2v2fF:undetectable","1hk3A-2v2fF:20.17"],["1I2W_A_CFXA1300_1","BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"LYS F 373;SER F 428;ASN F 430;THR F 543;LYS F 557;GLY F 559","None;MES F1653 (-3.1A);None;MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.6A)","0.74A","1i2wA-2v2fF:17.1","1i2wA-2v2fF:21.67"],["1I2W_A_CFXA1300_1","BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"SER F 370;SER F 428;ASN F 430;THR F 543;LYS F 557;GLY F 559","MES F1653 (-2.7A);MES F1653 (-3.1A);None;MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.6A)","0.79A","1i2wA-2v2fF:17.1","1i2wA-2v2fF:21.67"],["1MMW_A_H4BA1760_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",4,"MET F 583;ARG F 366;VAL F 329;GLU F 582","None;None;None;MES F1653 (-3.5A)","1.39A","1mmwA-2v2fF:undetectable;1mmwB-2v2fF:undetectable","1mmwA-2v2fF:23.49;1mmwB-2v2fF:23.49"],["1N2X_B_SAMB402_1","S-ADENOSYL-METHYLTRANSFERASE MRAW","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",4,"ASP F 335;VAL F 336;SER F 592;ASP F 303","None","1.35A","1n2xB-2v2fF:undetectable","1n2xB-2v2fF:21.46"],["1YMX_A_CFXA1001_1","BETA-LACTAMASE CTX-M-9","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"SER F 370;SER F 428;ASN F 430;THR F 543;LYS F 557;GLY F 559","MES F1653 (-2.7A);MES F1653 (-3.1A);None;MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.6A)","0.78A","1ymxA-2v2fF:17.7","1ymxA-2v2fF:24.69"],["2D55_C_DVAC8_0","ACTINOMYCIN D","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",3,"PRO F 380;THR F 376;PRO F 374","None","0.85A","2d55C-2v2fF:undetectable","2d55C-2v2fF:3.26"],["2YOE_C_FL7C1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",4,"GLY F 559;ILE F 454;THR F 376;TYR F 456","MES F1653 (-3.6A);None;None;None","0.90A","2yoeB-2v2fF:undetectable;2yoeC-2v2fF:undetectable","2yoeB-2v2fF:19.80;2yoeC-2v2fF:19.80"],["2YZQ_A_SAMA6075_0","PUTATIVE UNCHARACTERIZED PROTEIN PH1780","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",5,"THR F 300;VAL F 302;ILE F 342;GLU F 481;GLN F 344","None","1.20A","2yzqA-2v2fF:undetectable","2yzqA-2v2fF:21.46"],["3HLW_A_CE3A301_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"LYS F 373;SER F 428;ASN F 430;THR F 543;LYS F 557;GLY F 559","None;MES F1653 (-3.1A);None;MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.6A)","0.68A","3hlwA-2v2fF:17.6","3hlwA-2v2fF:24.69"],["3HLW_B_CE3B302_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"SER F 428;ASN F 430;THR F 543;LYS F 557;THR F 558;GLY F 559","MES F1653 (-3.1A);None;MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A)","0.48A","3hlwB-2v2fF:17.8","3hlwB-2v2fF:24.69"],["3KP6_B_SALB3001_1","TRANSCRIPTIONAL REGULATOR TCAR;TRANSCRIPTIONAL REGULATOR TCAR","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",4,"GLU F 627;HIS F 309;MET F 621;ILE F 622","None","1.26A","3kp6A-2v2fF:undetectable;3kp6B-2v2fF:undetectable","3kp6A-2v2fF:18.83;3kp6B-2v2fF:18.83"],["3L4D_A_TPFA490_1","STEROL 14-ALPHA DEMETHYLASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",4,"TYR F 618;ALA F 488;ALA F 491;MET F 535","None","0.96A","3l4dA-2v2fF:undetectable","3l4dA-2v2fF:19.12"],["3N5V_A_H4BA760_1","NITRIC OXIDE SYNTHASE;NITRIC OXIDE SYNTHASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",4,"MET F 583;ARG F 366;VAL F 329;GLU F 582","None;None;None;MES F1653 (-3.5A)","1.38A","3n5vA-2v2fF:undetectable;3n5vB-2v2fF:undetectable","3n5vA-2v2fF:23.81;3n5vB-2v2fF:23.81"],["3N5Y_A_H4BA760_1","NITRIC OXIDE SYNTHASE;NITRIC OXIDE SYNTHASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",4,"MET F 583;ARG F 366;VAL F 329;GLU F 582","None;None;None;MES F1653 (-3.5A)","1.34A","3n5yA-2v2fF:undetectable;3n5yB-2v2fF:undetectable","3n5yA-2v2fF:23.81;3n5yB-2v2fF:23.81"],["3N5Z_A_H4BA760_1","NITRIC OXIDE SYNTHASE;NITRIC OXIDE SYNTHASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",4,"MET F 583;ARG F 366;VAL F 329;GLU F 582","None;None;None;MES F1653 (-3.5A)","1.36A","3n5zA-2v2fF:undetectable;3n5zB-2v2fF:undetectable","3n5zA-2v2fF:23.81;3n5zB-2v2fF:23.81"],["3NY4_A_SMXA308_1","BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"SER F 428;THR F 543;LYS F 557;THR F 558;GLY F 559;THR F 560","MES F1653 (-3.1A);MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A);MES F1653 (-3.6A)","0.70A","3ny4A-2v2fF:16.4","3ny4A-2v2fF:19.70"],["3Q07_A_WPPA300_1","BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",5,"LYS F 373;SER F 428;ASN F 430;LYS F 557;GLY F 559","None;MES F1653 (-3.1A);None;MES F1653 ( 4.0A);MES F1653 (-3.6A)","0.61A","3q07A-2v2fF:17.6","3q07A-2v2fF:24.69"],["3Q9A_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",4,"MET F 583;ARG F 366;VAL F 329;GLU F 582","None;None;None;MES F1653 (-3.5A)","1.39A","3q9aA-2v2fF:undetectable;3q9aB-2v2fF:undetectable","3q9aA-2v2fF:23.81;3q9aB-2v2fF:23.81"],["4EUZ_A_MEMA401_1","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",7,"LYS F 373;SER F 428;ASN F 430;THR F 543;LYS F 557;THR F 558;GLY F 559","None;MES F1653 (-3.1A);None;MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A)","0.85A","4euzA-2v2fF:17.7","4euzA-2v2fF:24.08"],["4EUZ_A_MEMA401_1","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",7,"LYS F 373;SER F 428;THR F 543;LYS F 557;THR F 558;GLY F 559;THR F 560","None;MES F1653 (-3.1A);MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A);MES F1653 (-3.6A)","0.95A","4euzA-2v2fF:17.7","4euzA-2v2fF:24.08"],["4FH2_A_0RNA303_1","BETA-LACTAMASE SHV-1","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",5,"SER F 428;ASN F 430;LYS F 557;THR F 558;GLY F 559","MES F1653 (-3.1A);None;MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A)","0.70A","4fh2A-2v2fF:16.6","4fh2A-2v2fF:21.21"],["4MA7_A_P2ZA301_1","MAJOR PRION PROTEIN","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",4,"VAL F 538;LEU F 539;ILE F 622;VAL F 595","None","0.91A","4ma7A-2v2fF:undetectable","4ma7A-2v2fF:13.08"],["4MM4_B_8PRB603_2","TRANSPORTER","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",3,"SER F 331;MET F 593;ASP F 581","None","0.92A","4mm4B-2v2fF:undetectable","4mm4B-2v2fF:20.19"],["4NQA_A_9CRA501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",5,"ILE F 375;ALA F 379;LEU F 449;ALA F 445;VAL F 585","None","1.17A","4nqaA-2v2fF:undetectable","4nqaA-2v2fF:21.74"],["4PM5_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"SER F 428;ASN F 430;THR F 543;LYS F 557;THR F 558;GLY F 559","MES F1653 (-3.1A);None;MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A)","0.65A","4pm5A-2v2fF:17.9","4pm5A-2v2fF:24.44"],["4PM7_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",5,"LYS F 373;ASN F 430;THR F 543;LYS F 557;GLY F 559","None;None;MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.6A)","0.68A","4pm7A-2v2fF:17.9","4pm7A-2v2fF:24.44"],["4PM7_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",5,"SER F 428;ASN F 430;THR F 543;LYS F 557;GLY F 559","MES F1653 (-3.1A);None;MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.6A)","0.68A","4pm7A-2v2fF:17.9","4pm7A-2v2fF:24.44"],["4PM9_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"SER F 428;ASN F 430;THR F 543;LYS F 557;THR F 558;GLY F 559","MES F1653 (-3.1A);None;MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A)","0.67A","4pm9A-2v2fF:17.7","4pm9A-2v2fF:24.44"],["4X1K_D_LOCD502_1","TUBULIN ALPHA CHAIN;TUBULIN BETA CHAIN","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",4,"ASN F 274;SER F 331;ALA F 361;VAL F 362","None","1.41A","4x1kC-2v2fF:undetectable","4x1kC-2v2fF:23.38"],["5VUJ_A_H4BA802_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",4,"MET F 583;ARG F 366;VAL F 329;GLU F 582","None;None;None;MES F1653 (-3.5A)","1.34A","5vujA-2v2fF:undetectable;5vujB-2v2fF:undetectable","5vujA-2v2fF:23.81;5vujB-2v2fF:23.81"],["5ZMQ_K_PACK1_0","SERINE PROTEASE NS3;PEPTIDE PAC-DLY-DLY-DAR","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",3,"ALA F 343;VAL F 279;TYR F 501","None","0.71A","5zmqH-2v2fF:undetectable","5zmqH-2v2fF:19.32"],["6B5Y_B_9F2B400_1","BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"SER F 428;THR F 543;LYS F 557;THR F 558;GLY F 559;THR F 560","MES F1653 (-3.1A);MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A);MES F1653 (-3.6A)","0.73A","6b5yB-2v2fF:7.2","6b5yB-2v2fF:12.50"],["6B5Y_D_9F2D400_1","BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"SER F 428;THR F 543;LYS F 557;THR F 558;GLY F 559;THR F 560","MES F1653 (-3.1A);MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A);MES F1653 (-3.6A)","0.81A","6b5yD-2v2fF:17.4","6b5yD-2v2fF:12.50"],["6B68_B_9F2B301_1","BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"SER F 428;THR F 543;LYS F 557;THR F 558;GLY F 559;THR F 560","MES F1653 (-3.1A);MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A);MES F1653 (-3.6A)","0.59A","6b68B-2v2fF:17.4","6b68B-2v2fF:12.50"],["6B68_D_9F2D400_1","BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",5,"SER F 428;THR F 543;LYS F 557;GLY F 559;THR F 560","MES F1653 (-3.1A);MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.6A);MES F1653 (-3.6A)","0.64A","6b68D-2v2fF:17.5","6b68D-2v2fF:12.50"],["6B69_B_9F2B301_1","BETA-LACTAMASE;BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"SER F 428;THR F 543;LYS F 557;THR F 558;GLY F 559;THR F 560","MES F1653 (-3.1A);MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A);MES F1653 (-3.6A)","0.56A","6b69A-2v2fF:17.1;6b69B-2v2fF:17.2","6b69A-2v2fF:12.50;6b69B-2v2fF:12.50"],["6B69_D_9F2D301_1","BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"SER F 370;SER F 428;THR F 543;LYS F 557;THR F 558;GLY F 559","MES F1653 (-2.7A);MES F1653 (-3.1A);MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A)","0.74A","6b69D-2v2fF:7.3","6b69D-2v2fF:12.50"],["6B69_D_9F2D301_1","BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"SER F 428;THR F 543;LYS F 557;THR F 558;GLY F 559;THR F 560","MES F1653 (-3.1A);MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A);MES F1653 (-3.6A)","0.57A","6b69D-2v2fF:7.3","6b69D-2v2fF:12.50"],["6B6A_B_9F2B301_1","BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"SER F 428;THR F 543;LYS F 557;THR F 558;GLY F 559;THR F 560","MES F1653 (-3.1A);MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A);MES F1653 (-3.6A)","0.62A","6b6aB-2v2fF:17.6","6b6aB-2v2fF:12.50"],["6B6D_A_9F2A302_1","BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"SER F 370;SER F 428;THR F 543;LYS F 557;THR F 558;GLY F 559","MES F1653 (-2.7A);MES F1653 (-3.1A);MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A)","0.84A","6b6dA-2v2fF:17.3","6b6dA-2v2fF:12.50"],["6B6D_A_9F2A302_1","BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"SER F 428;THR F 543;LYS F 557;THR F 558;GLY F 559;THR F 560","MES F1653 (-3.1A);MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A);MES F1653 (-3.6A)","0.78A","6b6dA-2v2fF:17.3","6b6dA-2v2fF:12.50"],["6B6E_A_9F2A302_1","BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"SER F 370;SER F 428;THR F 543;LYS F 557;THR F 558;GLY F 559","MES F1653 (-2.7A);MES F1653 (-3.1A);MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A)","0.81A","6b6eA-2v2fF:17.5","6b6eA-2v2fF:12.50"],["6B6E_A_9F2A302_1","BETA-LACTAMASE","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",6,"SER F 428;THR F 543;LYS F 557;THR F 558;GLY F 559;THR F 560","MES F1653 (-3.1A);MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.8A);MES F1653 (-3.6A);MES F1653 (-3.6A)","0.65A","6b6eA-2v2fF:17.5","6b6eA-2v2fF:12.50"],["6C79_A_CE3A301_1","BETA-LACTAMASE TOHO-1","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",5,"SER F 428;ASN F 430;THR F 543;LYS F 557;GLY F 559","MES F1653 (-3.1A);None;MES F1653 (-3.7A);MES F1653 ( 4.0A);MES F1653 (-3.6A)","0.47A","6c79A-2v2fF:17.6","6c79A-2v2fF:13.35"],["6H7L_A_Y00A406_0","BETA-1 ADRENERGIC RECEPTOR","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",5,"VAL F 298;SER F 480;SER F 479;ASN F 359;VAL F 279","None","1.40A","6h7lA-2v2fF:undetectable","6h7lA-2v2fF:12.90"],["6H7L_B_Y00B405_0","BETA-1 ADRENERGIC RECEPTOR","2v2f","PENICILLIN BINDING PROTEIN 1A","Streptococcus pneumoniae",5,"VAL F 298;SER F 480;SER F 479;ASN F 359;VAL F 279","None","1.42A","6h7lB-2v2fF:undetectable","6h7lB-2v2fF:12.90"]]